Figure 2
Figure 2. Primary IDH1/2MT AML/MDS cells are not sensitized to (A) 5-azacitidine, (B) cytarabine, (C) daunorubicin or (D) decitabine, compared with primary IDH1/2WT AML/MDS cells.

Primary IDH1/2MT AML/MDS cells are not sensitized to (A) 5-azacitidine, (B) cytarabine, (C) daunorubicin or (D) decitabine, compared with primary IDH1/2WT AML/MDS cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal